Norman Sharpe
Cardiovascular risk assessment and management (including diabetes) is the keystone in the heart health continuum linking population health and clinical care. Systematic and focused implementation of the Cardiovascular Risk Guideline (NZGG 2003) through primary care offers the opportunity for substantial improvement in heart health outcomes and reduction of disparities in a reasonably short period of time. This implementation challenge requires a team based approach and appropriate resources and should be given topmost priority.
Norman Sharpe was formerly Head of the Department of Medicine and Head of the School of Medicine in the University of Auckland.
He was inaugural Chair of the New Zealand Guidelines Group and a member of the expert advisory group for the New Zealand Health Strategy 2000. His research interests have been broad spanning preventive and clinical cardiology. He is currently Emeritus Professor in the University of Auckland and Medical Director of the National Heart Foundation of New Zealand.
Wise Use of Antibiotics 2007
08-August-2007
The Wise use of Antibiotics is in its tenth year. It aims to raise...
Launch of the Wise Use of Antibiotics campaign
10-August-2006
Do you need pills for winter ills?
With cold and flu season upon...
One Heart Many Lives campaign up and running in the Hawke's Bay
02-June-2006
The PHARMAC team are working together with Hawke's Bay DHB and a ra...
Conference DVD available now
22-November-2005
The 2005 WCMAD Conference DVD is available in two versions. The edited...
Antibiotic resistance still growing
10-October-2005
Some bacteria are becoming resistant to a number of antibiotics at a...
PHARMAC and Social Marketing
10-October-2005
PHARMAC uses social marketing techniques in the development and...